杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jul 12 2023

Full Issue

Perspectives: Is Treating Mental Health With Psychedelics Worth The Risk?; RSV Vaccines Are On The Horizon

Read recent commentaries about drug-cost issues.

Psychedelic drugs like ketamine, which is already legal as an anesthetic, are promising new treatments for many psychiatric disorders, including addictions. But these medicines also carry significant risks. (Maia Szalavitz, 7/9)

In what health experts have described as a needed step forward in medicine, adults over 60 will be able to be vaccinated this fall against RSV, a virus that the Centers for Disease Control and Prevention estimates to cause between 60,000鈥160,000 hospitalizations and 6,000鈥10,000 deaths among older Americans per year through respiratory illness. (7/11)

On April 17, 2023, Nigeria approved a promising new malaria vaccine. It's called R21, and in early trials, up to 80% of kids who were vaccinated did not develop malaria. (Tolani Yesufu, 7/11)

A warning appeared on Tripadvisor on May 25, 2020: 鈥淐abo pharmacies selling fentanyl laced pills.鈥 The person posting under the moniker Spreadingfacts wrote, 鈥淢y brother passed away last year after buying pills at a pharmacy in Cabo.鈥 Over several posts, the writer said their brother died after buying what he thought were Oxycontin pills. When his blood was tested it revealed the deadly presence of fentanyl. (Minerva Canto, 7/10)

Eisai Co. and Biogen Inc.鈥檚 Alzhiemer鈥檚 drug Leqembi has been granted full approval by the Food and Drug Administration, making it the first disease-slowing drug to secure that full blessing. (Lisa Jarvis, 7/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
  • Thursday, May 21
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF